Krebs Biochemicals & Industries (BOM:524518) Long-Term Debt: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524518 Krebs Biochemicals & Industries Ltd BOM:524518
41 GF Score
Price ₹56.43
GF Value ₹43.03
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Krebs Biochemicals & Industries Long-Term Debt?

Krebs Biochemicals & Industries BOM:524518 -2.34% 41 Long-Term Debt is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:524518 with a GF Score™ of 41/100 and a GF Value™ of ₹43.03 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Krebs Biochemicals & Industries's Long-Term Debt for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Krebs Biochemicals & Industries's quarterly Long-Term Debt declined from Dec. 2025 (₹1,650.0 Mil) to Mar. 2026 (₹1,635.5 Mil) and declined from Mar. 2026 (₹1,635.5 Mil) to Jun. 2026 (₹0.0 Mil).

Krebs Biochemicals & Industries's annual Long-Term Debt declined from Mar. 2024 (₹1,835.0 Mil) to Mar. 2025 (₹1,612.5 Mil) but then increased from Mar. 2025 (₹1,612.5 Mil) to Mar. 2026 (₹1,635.5 Mil).

Krebs Biochemicals & Industries  (BOM:524518) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Krebs Biochemicals & Industries Long-Term Debt Related Terms

Krebs Biochemicals & Industries Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Krebs Biochemicals & Industries's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krebs Biochemicals & Industries Long-Term Debt Chart

Krebs Biochemicals & Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,329.30 1,732.47 1,835.00 1,612.50 1,635.50

Krebs Biochemicals & Industries Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,638.00 1,650.00 1,635.50 0.00
BOM:524518
41GF Score
Krebs Biochemicals & Industries Ltd BOM:524518
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹0.0 Mil mean?
Krebs Biochemicals & Industries (BOM:524518) has a Long-Term Debt of ₹0.0 Mil as of Jun. 2026.
Is Krebs Biochemicals & Industries' Long-Term Debt too high?
Krebs Biochemicals & Industries' current Long-Term Debt is ₹0.0 Mil. Overall, Krebs Biochemicals & Industries has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krebs Biochemicals & Industries' Long-Term Debt compare to ZTS?
Krebs Biochemicals & Industries' Long-Term Debt of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Krebs Biochemicals & Industries's current Long-Term Debt is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krebs Biochemicals & Industries stock overvalued right now?
Based on GuruFocus' analysis, Krebs Biochemicals & Industries (BOM:524518) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹43.03, compared to a current price of ₹56.43 — trading 31.1% above its estimated fair value. The current Long-Term Debt is ₹0.0 Mil. Krebs Biochemicals & Industries' overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Krebs Biochemicals & Industries (BOM:524518), the current Long-Term Debt is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krebs Biochemicals & Industries (BOM:524518) Overvalued in 2026?

Based on GuruFocus' analysis, Krebs Biochemicals & Industries stock appears to be overvalued. The current stock price of ₹56.43 is trading 31.1% above its estimated GF Value™ of ₹43.03. GuruFocus considers Krebs Biochemicals & Industries to be Significantly Overvalued.

Key valuation signals for BOM:524518:

  • Long-Term Debt: ₹0.0 Mil
  • GF Value™: ₹43.03 vs. price of ₹56.43 (31.1% above fair value)
  • GF Score™: 41/100 with 4 warning signs

No single metric tells the full story. See the BOM:524518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krebs Biochemicals & Industries Business Description

Other Exchanges KREBSBIO:India
Address Kothapalli Village, Kasimkota Mandal, Anakapalli, Vishakapatnam, AP, IND, 531 031
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.
41GF Score

Get the complete analysis for BOM:524518

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹56.43
Price
₹43.03
GF Value